Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Biblioteca Digital de Teses e Dissertações da UFC |
Texto Completo: | http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=4509 |
Resumo: | Ulcer can be defined as a chronic inflammatory disease of the stomach and duodenum, which appears as a lesion in the digestive tract, which extends through the mucosa muscle or more deeply. The ulcer usually occurs because of an imbalance between protective and agrssive factors of the mucosa. Esculin (ESC) (6.7-Dihydroxycoumarin-6-O-Glucoside) was evaluated in models ethanol or indomethacin-induced gastric lesions in mice. Esculin (12.5, 25 and 50 mg/kg, p.o.) significantly reduced gastric lesions induced by absolute ethanol (0.2 mL/animal) at 69.96, 72.94 and 79.33% respectively, showing no relationship dose-response at the doses studied. This gastroprotection was also evaluated microscopically showing that the ESC (25 mg/kg, p.o.) decreased the cell loss in the mucosa, submucosal edema and hemorrhage. Esculin (25 and 50 mg/kg, p.o.) also reduced significantly the gastric lesions induced by indomethacin (20 mg/kg, p.o.). Gastroprotective mechanism of ESC was examined in the dose of 25 mg/kg, in the model of gastric lesions induced by ethanol in mice. In animals pretreated with L-NAME (10 mg/kg, sc), an inhibitor of nitric oxide synthase, or with glibenclamide (5 mg/kg, i.p.), a drug that blocks ATP-dependent potassium channels, or indomethacin (10 mg/kg, p.o.), a nonselective inhibitor of cyclooxygenase, the gastroprotective effect of ESC was inhibited significantly, suggesting the involvement, at least in part, of nitric oxide, activation of potassium channels and endogenous prostaglandins in gastroprotective effect of ESC. Otherwise, the gastroprotective effect of ESC (25 mg/kg, p.o.) was not reversed in animals pretreated with capsazepine (5 mg/kg, i.p.), an antagonist of vanilloid receptor TRPV-1, demonstrating that there is activation of these receptors in the mechanism of action of ESC. This work was also evaluated the antioxidant mechanism of ESC as gastroprotective agent, against ethanol-induced lesions. Under our experimental conditions, the model of induction of ethanol injury caused changes in the antioxidant system of the gastric mucosa of mice as the decrease in the levels of sulfhydryl groups (GSH) and activity of superoxide dismutase (SOD), also showed increased activity catalase (CAT), the activity of myeloperoxidase (MPO) and the concentration of species that react with thiobarbituric acid (TBARS) as index of lipid peroxidation (LPO). Esculin in the model of ethanol did not interfere with the concentration of GSH, but increased SOD activity, allowed the restoration of normal CAT activity, normal levels of LPO and MPO activity. The data suggest that the ESC promotes gastroprotection against gastric lesions induced by ethanol or indomethacin in mice whose mechanisms include the involvement of endogenous prostaglandins, nitric oxide, and or, of KATP channels, as well as an antioxidant activity. |
id |
UFC_f3687df4d18e615f059e441c5ba51852 |
---|---|
oai_identifier_str |
oai:www.teses.ufc.br:3213 |
network_acronym_str |
UFC |
network_name_str |
Biblioteca Digital de Teses e Dissertações da UFC |
spelling |
info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisPharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved.Efeitos farmacolÃgicos da Esculina em modelos animais de lesÃo gÃstrica e possÃveis mecanismos envolvidos.2009-11-26Marta Maria de FranÃa Fonteles28529839315http://lattes.cnpq.br/0574180390413250Francisca ClÃa FlorenÃo de Sousa31636020372http://lattes.cnpq.br/1180465052181572Danielle MacÃdo Gaspar50160176387http://lattes.cnpq.br/156693733295736901117958345http://lattes.cnpq.br/8470314268717046Emiliano Ricardo Vasconcelos RiosUniversidade Federal do CearÃPrograma de PÃs-GraduaÃÃo em FarmacologiaUFCBR etanol indometacinaEsculin ethanol indomethacin gastric lesionFISIOLOGIA DA DIGESTAOUlcer can be defined as a chronic inflammatory disease of the stomach and duodenum, which appears as a lesion in the digestive tract, which extends through the mucosa muscle or more deeply. The ulcer usually occurs because of an imbalance between protective and agrssive factors of the mucosa. Esculin (ESC) (6.7-Dihydroxycoumarin-6-O-Glucoside) was evaluated in models ethanol or indomethacin-induced gastric lesions in mice. Esculin (12.5, 25 and 50 mg/kg, p.o.) significantly reduced gastric lesions induced by absolute ethanol (0.2 mL/animal) at 69.96, 72.94 and 79.33% respectively, showing no relationship dose-response at the doses studied. This gastroprotection was also evaluated microscopically showing that the ESC (25 mg/kg, p.o.) decreased the cell loss in the mucosa, submucosal edema and hemorrhage. Esculin (25 and 50 mg/kg, p.o.) also reduced significantly the gastric lesions induced by indomethacin (20 mg/kg, p.o.). Gastroprotective mechanism of ESC was examined in the dose of 25 mg/kg, in the model of gastric lesions induced by ethanol in mice. In animals pretreated with L-NAME (10 mg/kg, sc), an inhibitor of nitric oxide synthase, or with glibenclamide (5 mg/kg, i.p.), a drug that blocks ATP-dependent potassium channels, or indomethacin (10 mg/kg, p.o.), a nonselective inhibitor of cyclooxygenase, the gastroprotective effect of ESC was inhibited significantly, suggesting the involvement, at least in part, of nitric oxide, activation of potassium channels and endogenous prostaglandins in gastroprotective effect of ESC. Otherwise, the gastroprotective effect of ESC (25 mg/kg, p.o.) was not reversed in animals pretreated with capsazepine (5 mg/kg, i.p.), an antagonist of vanilloid receptor TRPV-1, demonstrating that there is activation of these receptors in the mechanism of action of ESC. This work was also evaluated the antioxidant mechanism of ESC as gastroprotective agent, against ethanol-induced lesions. Under our experimental conditions, the model of induction of ethanol injury caused changes in the antioxidant system of the gastric mucosa of mice as the decrease in the levels of sulfhydryl groups (GSH) and activity of superoxide dismutase (SOD), also showed increased activity catalase (CAT), the activity of myeloperoxidase (MPO) and the concentration of species that react with thiobarbituric acid (TBARS) as index of lipid peroxidation (LPO). Esculin in the model of ethanol did not interfere with the concentration of GSH, but increased SOD activity, allowed the restoration of normal CAT activity, normal levels of LPO and MPO activity. The data suggest that the ESC promotes gastroprotection against gastric lesions induced by ethanol or indomethacin in mice whose mechanisms include the involvement of endogenous prostaglandins, nitric oxide, and or, of KATP channels, as well as an antioxidant activity.A Ãlcera pÃptica pode ser definida como sendo uma doenÃa inflamatÃria crÃnica do estÃmago e duodeno, que se apresenta como uma lesÃo na mucosa do trato digestivo, que se estende atravÃs da musculatura da mucosa ou mais profundamente. A Ãlcera pÃptica geralmente ocorre devido a um desequilÃbrio entre os fatores de defesa e agressores da mucosa. Este trabalho teve como objetivo avaliar a atividade gastroprotetora da esculina, (6,7-diidroxicumarina-6-o-glicosÃdio), e identificar os mecanismos farmacolÃgicos envolvidos. A esculina foi avaliada em modelos de lesÃes gÃstricas induzidas por etanol absoluto (0,2 mL/animal) em camundongos swiss, nas doses 12,5, 25 e 50 mg/kg, v.o., os resultados mostraram a reduÃÃo das lesÃes gÃstricas induzidas por etanol em 69,96, 72,94 e 79,33 % respectivamente, nÃo mostrando relaÃÃo dose-resposta nas doses estudadas. Esta gastroproteÃÃo tambÃm foi avaliada microscopicamente mostrando que a ESC (25 mg/kg, v.o.) diminuiu a perda celular na mucosa, formaÃÃo de edema na submucosa e hemorragia. A ESC (25 e 50 mg/kg, v.o.), tambÃm, foi avaliada no modelo de lesÃo gÃstrica induzida por indometacina (20 mg/Kg, v.o.), mostrando uma reduÃÃo das lesÃes gÃstricas. O mecanismo gastroprotetor da ESC foi analisado na sua dose de 25 mg/Kg, em modelo de lesÃes gÃstricas induzidas por etanol em camundongos. Em animais prÃ-tratados com L-NAME (10 mg/Kg, s.c.), um inibidor da Ãxido nÃtrico sintase, ou com glibenclamida (5 mg/Kg, i.p.), droga bloqueadora de canais de potÃssio ATP-dependentes, ou indometacina (10 mg/Kg, v.o.), um inibidor nÃo seletivo da ciclooxigenase, o efeito gastroprotetor da ESC foi inibido significativamente, sugerindo o envolvimento, pelo menos em parte, do Ãxido nÃtrico, ativaÃÃo dos canais de potÃssio e prostaglandinas endÃgenas no efeito gastroprotetor da ESC. De outra forma, o efeito gastroprotetor da ESC (25 mg/Kg, v.o.) nÃo foi revertido em camundongos prÃ-tratados com capsazepina (5 mg/Kg, i.p.), um antagonista dos receptores vanilÃides TRPV-1, demonstrando assim que nÃo hà ativaÃÃo destes receptores no mecanismo de aÃÃo da ESC. Neste trabalho tambÃm foi avaliado a aÃÃo antioxidante da ESC como mecanismo gastroprotetor contra as lesÃes induzidas por etanol. Sob nossas condiÃÃes experimentais, o modelo de induÃÃo de lesÃo por etanol provocou alteraÃÃo no sistema antioxidante da mucosa gÃstrica dos camundongos, como a diminuiÃÃo nos nÃveis de grupamentos sulfidrila (GSH) e atividade da superÃxido dismutase (SOD), tambÃm observamos aumento da atividade da catalase (CAT), da atividade da mieloperoxidase (MPO) e da concentraÃÃo de espÃcies que reagem com o Ãcido tiobarbitÃrico (TBARs), como Ãndice de peroxidaÃÃo lipÃdica (LPO). A ESC no modelo de etanol nÃo interferiu com a concentraÃÃo de GSH, mas aumentou a atividade da SOD, permitiu o restabelecimento da atividade normal da CAT e de patamares normais de LPO e de atividade da MPO. Os dados obtidos sugerem que a ESC promove gastroproteÃÃo contra as lesÃes gÃstricas induzidas por etanol ou indometacina em camundongos, por mecanismos que incluem o envolvimento de prostaglandinas endÃgenas, Ãxido nÃtrico, e ou, dos canais de KATP, alÃm de uma aÃÃo antioxidante.Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgicohttp://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=4509application/pdfinfo:eu-repo/semantics/openAccessporreponame:Biblioteca Digital de Teses e Dissertações da UFCinstname:Universidade Federal do Cearáinstacron:UFC2019-01-21T11:17:48Zmail@mail.com - |
dc.title.en.fl_str_mv |
Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved. |
dc.title.alternative.pt.fl_str_mv |
Efeitos farmacolÃgicos da Esculina em modelos animais de lesÃo gÃstrica e possÃveis mecanismos envolvidos. |
title |
Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved. |
spellingShingle |
Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved. Emiliano Ricardo Vasconcelos Rios etanol indometacina Esculin ethanol indomethacin gastric lesion FISIOLOGIA DA DIGESTAO |
title_short |
Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved. |
title_full |
Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved. |
title_fullStr |
Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved. |
title_full_unstemmed |
Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved. |
title_sort |
Pharmacologicals effects of the esculin in animal models of gastric injury and possible machanisms involved. |
author |
Emiliano Ricardo Vasconcelos Rios |
author_facet |
Emiliano Ricardo Vasconcelos Rios |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
Marta Maria de FranÃa Fonteles |
dc.contributor.advisor1ID.fl_str_mv |
28529839315 |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/0574180390413250 |
dc.contributor.referee1.fl_str_mv |
Francisca ClÃa FlorenÃo de Sousa |
dc.contributor.referee1ID.fl_str_mv |
31636020372 |
dc.contributor.referee1Lattes.fl_str_mv |
http://lattes.cnpq.br/1180465052181572 |
dc.contributor.referee2.fl_str_mv |
Danielle MacÃdo Gaspar |
dc.contributor.referee2ID.fl_str_mv |
50160176387 |
dc.contributor.referee2Lattes.fl_str_mv |
http://lattes.cnpq.br/1566937332957369 |
dc.contributor.authorID.fl_str_mv |
01117958345 |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/8470314268717046 |
dc.contributor.author.fl_str_mv |
Emiliano Ricardo Vasconcelos Rios |
contributor_str_mv |
Marta Maria de FranÃa Fonteles Francisca ClÃa FlorenÃo de Sousa Danielle MacÃdo Gaspar |
dc.subject.por.fl_str_mv |
etanol indometacina |
topic |
etanol indometacina Esculin ethanol indomethacin gastric lesion FISIOLOGIA DA DIGESTAO |
dc.subject.eng.fl_str_mv |
Esculin ethanol indomethacin gastric lesion |
dc.subject.cnpq.fl_str_mv |
FISIOLOGIA DA DIGESTAO |
dc.description.sponsorship.fl_txt_mv |
Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico |
dc.description.abstract.por.fl_txt_mv |
Ulcer can be defined as a chronic inflammatory disease of the stomach and duodenum, which appears as a lesion in the digestive tract, which extends through the mucosa muscle or more deeply. The ulcer usually occurs because of an imbalance between protective and agrssive factors of the mucosa. Esculin (ESC) (6.7-Dihydroxycoumarin-6-O-Glucoside) was evaluated in models ethanol or indomethacin-induced gastric lesions in mice. Esculin (12.5, 25 and 50 mg/kg, p.o.) significantly reduced gastric lesions induced by absolute ethanol (0.2 mL/animal) at 69.96, 72.94 and 79.33% respectively, showing no relationship dose-response at the doses studied. This gastroprotection was also evaluated microscopically showing that the ESC (25 mg/kg, p.o.) decreased the cell loss in the mucosa, submucosal edema and hemorrhage. Esculin (25 and 50 mg/kg, p.o.) also reduced significantly the gastric lesions induced by indomethacin (20 mg/kg, p.o.). Gastroprotective mechanism of ESC was examined in the dose of 25 mg/kg, in the model of gastric lesions induced by ethanol in mice. In animals pretreated with L-NAME (10 mg/kg, sc), an inhibitor of nitric oxide synthase, or with glibenclamide (5 mg/kg, i.p.), a drug that blocks ATP-dependent potassium channels, or indomethacin (10 mg/kg, p.o.), a nonselective inhibitor of cyclooxygenase, the gastroprotective effect of ESC was inhibited significantly, suggesting the involvement, at least in part, of nitric oxide, activation of potassium channels and endogenous prostaglandins in gastroprotective effect of ESC. Otherwise, the gastroprotective effect of ESC (25 mg/kg, p.o.) was not reversed in animals pretreated with capsazepine (5 mg/kg, i.p.), an antagonist of vanilloid receptor TRPV-1, demonstrating that there is activation of these receptors in the mechanism of action of ESC. This work was also evaluated the antioxidant mechanism of ESC as gastroprotective agent, against ethanol-induced lesions. Under our experimental conditions, the model of induction of ethanol injury caused changes in the antioxidant system of the gastric mucosa of mice as the decrease in the levels of sulfhydryl groups (GSH) and activity of superoxide dismutase (SOD), also showed increased activity catalase (CAT), the activity of myeloperoxidase (MPO) and the concentration of species that react with thiobarbituric acid (TBARS) as index of lipid peroxidation (LPO). Esculin in the model of ethanol did not interfere with the concentration of GSH, but increased SOD activity, allowed the restoration of normal CAT activity, normal levels of LPO and MPO activity. The data suggest that the ESC promotes gastroprotection against gastric lesions induced by ethanol or indomethacin in mice whose mechanisms include the involvement of endogenous prostaglandins, nitric oxide, and or, of KATP channels, as well as an antioxidant activity. A Ãlcera pÃptica pode ser definida como sendo uma doenÃa inflamatÃria crÃnica do estÃmago e duodeno, que se apresenta como uma lesÃo na mucosa do trato digestivo, que se estende atravÃs da musculatura da mucosa ou mais profundamente. A Ãlcera pÃptica geralmente ocorre devido a um desequilÃbrio entre os fatores de defesa e agressores da mucosa. Este trabalho teve como objetivo avaliar a atividade gastroprotetora da esculina, (6,7-diidroxicumarina-6-o-glicosÃdio), e identificar os mecanismos farmacolÃgicos envolvidos. A esculina foi avaliada em modelos de lesÃes gÃstricas induzidas por etanol absoluto (0,2 mL/animal) em camundongos swiss, nas doses 12,5, 25 e 50 mg/kg, v.o., os resultados mostraram a reduÃÃo das lesÃes gÃstricas induzidas por etanol em 69,96, 72,94 e 79,33 % respectivamente, nÃo mostrando relaÃÃo dose-resposta nas doses estudadas. Esta gastroproteÃÃo tambÃm foi avaliada microscopicamente mostrando que a ESC (25 mg/kg, v.o.) diminuiu a perda celular na mucosa, formaÃÃo de edema na submucosa e hemorragia. A ESC (25 e 50 mg/kg, v.o.), tambÃm, foi avaliada no modelo de lesÃo gÃstrica induzida por indometacina (20 mg/Kg, v.o.), mostrando uma reduÃÃo das lesÃes gÃstricas. O mecanismo gastroprotetor da ESC foi analisado na sua dose de 25 mg/Kg, em modelo de lesÃes gÃstricas induzidas por etanol em camundongos. Em animais prÃ-tratados com L-NAME (10 mg/Kg, s.c.), um inibidor da Ãxido nÃtrico sintase, ou com glibenclamida (5 mg/Kg, i.p.), droga bloqueadora de canais de potÃssio ATP-dependentes, ou indometacina (10 mg/Kg, v.o.), um inibidor nÃo seletivo da ciclooxigenase, o efeito gastroprotetor da ESC foi inibido significativamente, sugerindo o envolvimento, pelo menos em parte, do Ãxido nÃtrico, ativaÃÃo dos canais de potÃssio e prostaglandinas endÃgenas no efeito gastroprotetor da ESC. De outra forma, o efeito gastroprotetor da ESC (25 mg/Kg, v.o.) nÃo foi revertido em camundongos prÃ-tratados com capsazepina (5 mg/Kg, i.p.), um antagonista dos receptores vanilÃides TRPV-1, demonstrando assim que nÃo hà ativaÃÃo destes receptores no mecanismo de aÃÃo da ESC. Neste trabalho tambÃm foi avaliado a aÃÃo antioxidante da ESC como mecanismo gastroprotetor contra as lesÃes induzidas por etanol. Sob nossas condiÃÃes experimentais, o modelo de induÃÃo de lesÃo por etanol provocou alteraÃÃo no sistema antioxidante da mucosa gÃstrica dos camundongos, como a diminuiÃÃo nos nÃveis de grupamentos sulfidrila (GSH) e atividade da superÃxido dismutase (SOD), tambÃm observamos aumento da atividade da catalase (CAT), da atividade da mieloperoxidase (MPO) e da concentraÃÃo de espÃcies que reagem com o Ãcido tiobarbitÃrico (TBARs), como Ãndice de peroxidaÃÃo lipÃdica (LPO). A ESC no modelo de etanol nÃo interferiu com a concentraÃÃo de GSH, mas aumentou a atividade da SOD, permitiu o restabelecimento da atividade normal da CAT e de patamares normais de LPO e de atividade da MPO. Os dados obtidos sugerem que a ESC promove gastroproteÃÃo contra as lesÃes gÃstricas induzidas por etanol ou indometacina em camundongos, por mecanismos que incluem o envolvimento de prostaglandinas endÃgenas, Ãxido nÃtrico, e ou, dos canais de KATP, alÃm de uma aÃÃo antioxidante. |
description |
Ulcer can be defined as a chronic inflammatory disease of the stomach and duodenum, which appears as a lesion in the digestive tract, which extends through the mucosa muscle or more deeply. The ulcer usually occurs because of an imbalance between protective and agrssive factors of the mucosa. Esculin (ESC) (6.7-Dihydroxycoumarin-6-O-Glucoside) was evaluated in models ethanol or indomethacin-induced gastric lesions in mice. Esculin (12.5, 25 and 50 mg/kg, p.o.) significantly reduced gastric lesions induced by absolute ethanol (0.2 mL/animal) at 69.96, 72.94 and 79.33% respectively, showing no relationship dose-response at the doses studied. This gastroprotection was also evaluated microscopically showing that the ESC (25 mg/kg, p.o.) decreased the cell loss in the mucosa, submucosal edema and hemorrhage. Esculin (25 and 50 mg/kg, p.o.) also reduced significantly the gastric lesions induced by indomethacin (20 mg/kg, p.o.). Gastroprotective mechanism of ESC was examined in the dose of 25 mg/kg, in the model of gastric lesions induced by ethanol in mice. In animals pretreated with L-NAME (10 mg/kg, sc), an inhibitor of nitric oxide synthase, or with glibenclamide (5 mg/kg, i.p.), a drug that blocks ATP-dependent potassium channels, or indomethacin (10 mg/kg, p.o.), a nonselective inhibitor of cyclooxygenase, the gastroprotective effect of ESC was inhibited significantly, suggesting the involvement, at least in part, of nitric oxide, activation of potassium channels and endogenous prostaglandins in gastroprotective effect of ESC. Otherwise, the gastroprotective effect of ESC (25 mg/kg, p.o.) was not reversed in animals pretreated with capsazepine (5 mg/kg, i.p.), an antagonist of vanilloid receptor TRPV-1, demonstrating that there is activation of these receptors in the mechanism of action of ESC. This work was also evaluated the antioxidant mechanism of ESC as gastroprotective agent, against ethanol-induced lesions. Under our experimental conditions, the model of induction of ethanol injury caused changes in the antioxidant system of the gastric mucosa of mice as the decrease in the levels of sulfhydryl groups (GSH) and activity of superoxide dismutase (SOD), also showed increased activity catalase (CAT), the activity of myeloperoxidase (MPO) and the concentration of species that react with thiobarbituric acid (TBARS) as index of lipid peroxidation (LPO). Esculin in the model of ethanol did not interfere with the concentration of GSH, but increased SOD activity, allowed the restoration of normal CAT activity, normal levels of LPO and MPO activity. The data suggest that the ESC promotes gastroprotection against gastric lesions induced by ethanol or indomethacin in mice whose mechanisms include the involvement of endogenous prostaglandins, nitric oxide, and or, of KATP channels, as well as an antioxidant activity. |
publishDate |
2009 |
dc.date.issued.fl_str_mv |
2009-11-26 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
status_str |
publishedVersion |
format |
masterThesis |
dc.identifier.uri.fl_str_mv |
http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=4509 |
url |
http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=4509 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal do Cearà |
dc.publisher.program.fl_str_mv |
Programa de PÃs-GraduaÃÃo em Farmacologia |
dc.publisher.initials.fl_str_mv |
UFC |
dc.publisher.country.fl_str_mv |
BR |
publisher.none.fl_str_mv |
Universidade Federal do Cearà |
dc.source.none.fl_str_mv |
reponame:Biblioteca Digital de Teses e Dissertações da UFC instname:Universidade Federal do Ceará instacron:UFC |
reponame_str |
Biblioteca Digital de Teses e Dissertações da UFC |
collection |
Biblioteca Digital de Teses e Dissertações da UFC |
instname_str |
Universidade Federal do Ceará |
instacron_str |
UFC |
institution |
UFC |
repository.name.fl_str_mv |
-
|
repository.mail.fl_str_mv |
mail@mail.com |
_version_ |
1643295139927425024 |